Interestingly, together with p53 activation, a reciprocal reduction of insulin-like growth factor-1 (IGF-1) was found, which was also linked in other studies to the progression from non-pathogenic steatosis to overt NASH [81,82]. The gene discussed is TP53; the disease is metabolic dysfunction-associated steatohepatitis.